TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | -2 | -4 | 17 | -19 | 123 | 19 |
| P | %wins | 33 | 0 | 33 | 100 | 33 | 33 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/22 16:29 | 6/1/22 | SEEL | Seelos Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | O'Connor Daniel J. | NY | D | P | 10 | 0.6118 | 0 | 16 | New | 16 | D | |||||||||||||||
11/7/18 12:08 | 11/7/18 | ONCS | Oncosec Medical Inc | NV | Health | Drug | Pharmaceutical Preparations | O'Connor Daniel J. | NJ | DO | CEO,P | P | 9 | 0.9100 | 0 | 10 | 60 | 27 | D | ||||||||||||||
2/6/18 09:15 | 2/5/18 | ONCS | Oncosec Medical Inc | NV | Health | Drug | Pharmaceutical Preparations | O'Connor Daniel J. | CA | DO | CEO | P | 25 | 1.50 | 0 | 17 | New | 17 | D | ||||||||||||||
4/2/14 06:09 | 3/31/14 | ADXS | Advaxis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | O'Connor Daniel | NJ | DO | CEO | P | 10 | 3.00 | 1 | 3 | 1 | 311 | D | -80 | -74 | -44 | -30 | -42 | -33 | -36 | 3 | -1 | -4 | -10 | 1 | 7 | 393 |
10/29/13 19:31 | 10/24/13 | ADXS | Advaxis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | O'Connor Daniel | NJ | DO | CEO | P.a | 54 | 4.00 | 1 | 14 | 28 | 61 | D | -80 | -32 | -55 | 13 | -38 | -25 | 1 | 7 | -1 | -1 | -2 | 20 | -31 | -15 |
10/28/13 21:30 | 10/24/13 | ADXS | Advaxis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | O'Connor Daniel | NJ | DO | CEO | P.d | 54 | 4.00 | 1 | 14 | 28 | 61 | D | -80 | -37 | -58 | 8 | -43 | -21 | -28 | 0 | 4 | -1 | 1 | 31 | -34 | -10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |